Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. A.A. (Adriaan) Voors

Publicaties

Acute Heart Failure: Transitioning From Symptom-Based Care to Remission

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial

Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial

Impact of Mild and Moderate Aortic Stenosis in Acute Heart Failure: Insights From RELAX-AHF-2

Iron Deficiency Definitions and their Clinical and Prognostic Associations Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure

Long-term outcomes of patients implanted with a HeartMate 3 left ventricular assist device - a real-world, single center, observational study

Nanoparticle-Mediated Delivery of Adenosine 5′-Monophosphate Enhances 5-Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure

Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD

Risk calculator of multimorbid risk of rehospitalization and death from heart failure: including the contribution of the gut microbiome

Pers/media

Men Have High Levels Of Enzyme Key To COVID-19

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Novità nel trattamento dello scompenso cardiaco acuto

Health Industry News

PRNewswire Latest Health News

EMPULSE shows empagliflozin benefit in acute heart failure

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse